维普中文期刊产品整合服务
37篇 您的检索式:作者名="GHAVAMZADEH A"
    题名 作者 年代 出处 被引量
1Periph- eral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class 1 and II beta thalassemia major显示文摘GHAVAMZADEH A IRAVANI M ASHOURI A 2008Biol Brood Marrow Transplant2008,14,3:1
2Treatment of acute promyelocytic leukemia with arsemc trioxide without ATRA and/or chemotherapy 显示文摘Ghavamzadeh A Alimoghaddaml K Ghaffari SH 2006Ann Oncol2006,17,1:1
3Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy显示文摘Ghavamzadeh A Alimoghaddam K Ghaffari SH 2006Ann Oncol2006,17,1:1
4Phase Ⅱ study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukemia显示文摘Ghavamzadeh A Alimoghaddam K Rostami S 2011J Clin Oncol2011,29,20:1
5Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia显示文摘Yaghmaie M Ghaffari SH Ghavamzadeh A 2008Arch Iran Med2008,11,3:1
6Phase II study of single-agent arsenictrioxide for the front-line therapy of acute promyelo-cytic leukemia 显示文摘GHAVAMZADEH A ALIMOGHADDAM K ROS-TAMI S 2011J Clin Oncol2011,29,:1
7PhaseⅡstudy of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukemia显示文摘Ghavamzadeh A Alimoghaddam K Rostami S 2011J Clin Oncol2011,29,20:1
8Thyroid, parathyroid, gonadal, and pancreatic beta-cell func- tion after bone marrow transplantation with chemotherapy on ly conditioning 显示文摘GHAVAMZADEH A LARIJANI B JAHANI M 2003Transplantation Proceedings2003,35,8:1
9Frequency of BCR-ABL fusion transcripts in Iranian patients with chronic myeloid leukemia显示文摘Yaghmaie M Ghaffari SH Ghavamzadeh A 2008Arch Iranian Med2008,11,3:1
10Treatment of acute promyelocytic leukemia without ATRA and/or chemotherapy显示文摘GHAVAMZADEH A ALIMOGHADAM K 2006Ann Oncol2006,107,:1
11Phase Ⅱ study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukemia显示文摘Ghavamzadeh A Alimoghaddam K Rostami S 2011J Clin Oncol2011,29,20:1
12Peripheral blood versns bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with class Ⅰ and Ⅱ β-thalassemia major显示文摘Ghavamzadeh A Iravani M Ashouri A 0,,:1
13Peripheral blood versus bone marrow as a source of hematopoietic stem cells for allogeneic transplantation in children with classⅠandⅡβ-thalassemia major显示文摘Ghavamzadeh A Iravani M Ashouri A 2008Biol Blood Marrow Transplant2008,14,3:1
14Phase II study of single-agent arsenic trioxide for the front-line therapy of acute promyelocytic leukemia显示文摘Ghavamzadeh A Alimoghaddam K Rostami S 2011J Clin Oncol2011,29,20:1
15Treatment of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy 显示文摘Ghavamzadeh A Mimoghaddam K Ghaffari SH 2006Ann Oncol2006,17,1:1
16Phase II study of single-agent arsenic trioxide for the front-line therapy of acute promy- elocytic leukemia 显示文摘Ghavamzadeh A Alimoghaddam K Rostami S 2011J Clin Onco12011,29,20:1
17The detection of disseminated tumor cells in bone marrow and peripheral blood of gastric cancer patients by multimarker (CEA, CK20, TFF1 and MUC2) quantitative real-time PCR显示文摘Dardaei L Shahsavani R Ghavamzadeh A 2011Clin Biochem2011,44,4:1
18Phase lI study of single-agent arsenic trioxide for the from-line therapy of a- cute promyelocytic leukemia 显示文摘Ghavamzadeh A Alimoghaddam K Rostami S 2011J Clin Oncol2011,29,20:1
19Treatment of relapsed acute promyelocytic leukemia by arsenic trioxide in Iran显示文摘Alimoghaddam K Ghavamzadeh A Jahani M 2011Arch Iran Med2011,14,3:1
20Treatment Of acute promyelocytic leukemia with arsenic trioxide without ATRA and/or chemotherapy显示文摘Ghavamzadeh A Alimoghaddaml K Ghaffari SH 0,,01:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费